Fig. 3.
Response to nanoparticle albumin-bound paclitaxel (nab-PTX) therapy. a Waterfall plot to show the efficacy of nab-PTX therapy. b Clinical response rate after nab-PTX therapy. Each subtype is indicated. c Immunohistochemistry for PARC expression. Representative cases are indicated. Scores 0 and +1 indicate negativity, and 2+ and 3+ indicate positivity. d The tumor shrinkage rate depending on SPARC expression in tumor. The average rate with an error bar for the standard division is shown